These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9023415

  • 1. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N, Hoshino T, Kikuchi M, Hayashi A, Itoh K.
    Cell Immunol; 1997 Feb 01; 175(2):101-10. PubMed ID: 9023415
    [Abstract] [Full Text] [Related]

  • 2. HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer.
    Hoshino T, Seki N, Kikuchi M, Kuramoto T, Iwamoto O, Kodama I, Koufuji K, Takeda J, Itoh K.
    Int J Cancer; 1997 Mar 17; 70(6):631-8. PubMed ID: 9096641
    [Abstract] [Full Text] [Related]

  • 3. HLA class I-restricted and tumor-specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancers.
    Toh U, Yamana H, Nakao M, Imai Y, Seki N, Takasu H, Kaneshige T, Fujita H, Shirouzu K, Itoh K.
    Cell Immunol; 1997 May 01; 177(2):137-43. PubMed ID: 9178640
    [Abstract] [Full Text] [Related]

  • 4. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
    Stevens EJ, Jacknin L, Robbins PF, Kawakami Y, el Gamil M, Rosenberg SA, Yannelli JR.
    J Immunol; 1995 Jan 15; 154(2):762-71. PubMed ID: 7814882
    [Abstract] [Full Text] [Related]

  • 5. Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.
    Shichijo S, Azuma K, Komatsu N, Ito M, Maeda Y, Ishihara Y, Itoh K.
    Clin Cancer Res; 2004 Sep 01; 10(17):5828-36. PubMed ID: 15355913
    [Abstract] [Full Text] [Related]

  • 6. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
    Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S.
    J Cancer Res Clin Oncol; 2002 Nov 01; 128(11):581-8. PubMed ID: 12458337
    [Abstract] [Full Text] [Related]

  • 7. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
    Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, Yao A, Hirai T, Takabayashi A, Shichijo S, Itoh K.
    Clin Cancer Res; 2004 Oct 01; 10(19):6695-702. PubMed ID: 15475460
    [Abstract] [Full Text] [Related]

  • 8. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.
    Nishizaka S, Gomi S, Harada K, Oizumi K, Itoh K, Shichijo S.
    Cancer Res; 2000 Sep 01; 60(17):4830-7. PubMed ID: 10987294
    [Abstract] [Full Text] [Related]

  • 9. Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer.
    Gohara R, Nakao M, Ogata Y, Isomoto H, Oizumi K, Itoh K.
    Jpn J Cancer Res; 1997 Feb 01; 88(2):198-204. PubMed ID: 9119749
    [Abstract] [Full Text] [Related]

  • 10. Gene and peptide analyses of newly defined lung cancer antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.
    Yamada A, Kawano K, Koga M, Takamori S, Nakagawa M, Itoh K.
    Cancer Res; 2003 Jun 01; 63(11):2829-35. PubMed ID: 12782588
    [Abstract] [Full Text] [Related]

  • 11. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs.
    Gomi S, Nakao M, Niiya F, Imamura Y, Kawano K, Nishizaka S, Hayashi A, Sobao Y, Oizumi K, Itoh K.
    J Immunol; 1999 Nov 01; 163(9):4994-5004. PubMed ID: 10528204
    [Abstract] [Full Text] [Related]

  • 12. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene.
    Hogan KT, Eisinger DP, Cupp SB, Lekstrom KJ, Deacon DD, Shabanowitz J, Hunt DF, Engelhard VH, Slingluff CL, Ross MM.
    Cancer Res; 1998 Nov 15; 58(22):5144-50. PubMed ID: 9823325
    [Abstract] [Full Text] [Related]

  • 13. Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer.
    Kawano K, Gomi S, Tanaka K, Tsuda N, Kamura T, Itoh K, Yamada A.
    Cancer Res; 2000 Jul 01; 60(13):3550-8. PubMed ID: 10910068
    [Abstract] [Full Text] [Related]

  • 14. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, Brugger W.
    Cancer Res; 1998 Feb 15; 58(4):732-6. PubMed ID: 9485028
    [Abstract] [Full Text] [Related]

  • 15. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    Linehan DC, Goedegebuure PS, Peoples GE, Rogers SO, Eberlein TJ.
    J Immunol; 1995 Nov 01; 155(9):4486-91. PubMed ID: 7594611
    [Abstract] [Full Text] [Related]

  • 16. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER.
    Cancer Res; 1999 Sep 15; 59(18):4642-50. PubMed ID: 10493519
    [Abstract] [Full Text] [Related]

  • 17. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
    Eura M, Chikamatsu K, Katsura F, Obata A, Sobao Y, Takiguchi M, Song Y, Appella E, Whiteside TL, DeLeo AB.
    Clin Cancer Res; 2000 Mar 15; 6(3):979-86. PubMed ID: 10741724
    [Abstract] [Full Text] [Related]

  • 18. HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma.
    Nakao M, Yamana H, Imai Y, Toh Y, Toh U, Kimura A, Yanoma S, Kakegawa T, Itoh K.
    Cancer Res; 1995 Oct 01; 55(19):4248-52. PubMed ID: 7671230
    [Abstract] [Full Text] [Related]

  • 19. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J, Hirohashi Y, Torigoe T, Michifuri Y, Yamamoto T, Tamura Y, Kamiguchi K, Miyazaki A, Yamaguchi A, Hariu H, Hiratsuka H, Sato N.
    Hum Immunol; 2009 Feb 01; 70(2):89-95. PubMed ID: 19124056
    [Abstract] [Full Text] [Related]

  • 20. HLA-A2402-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of a child with Wilms' tumor.
    Nagai K, Yamada A, Eguchi H, Kato H, Itoh K.
    Pediatr Res; 1997 Jul 01; 42(1):122-7. PubMed ID: 9212047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.